tirzepatide obstructive sleep apnea fda approval 2024 🚨 BREAKING: A New Era for Treatment! 🚨, For the first time ever, the has approved Zepbound (tirzepatide) to treat sleep apnea (OSA) in adults with obesity!, 🌙 Clinical FDA approves weight-loss drug Zepbound

We explored what responsible-AI means in clinical contexts: from realistic threat models (with evidences) and jailbreak scenarios to aligning systems with general & clinical values alongside establishing practical guardrails through evaluation, red-teaming, documentation, and governance

In the future, natural plant compounds could enhance the therapeutic effects on ferroptosis in AKI by targeting pathways, receptors, inhibitors, activators, and other methods

Risk of blood clot formation, potentially leading to stroke if not managed properly

10.1038/s41591-018-0104-9 17 FruciB.GiulianoS.MazzaA.MalaguarneraR.BelfioreA

PMID: 97 EmensLADavidsonNE

This synergy hypothesis that GIP and glucagon receptor activation potentiate each others metabolic effects when combined with GLP-1 is one of the most important pharmacological questions in modern metabolic research